Choi Han Wook 4
4 · Vor Biopharma Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Choi Han Wook
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-03+52,500→ 52,500 total - Award
Employee Stock Option (right to buy)
2025-02-03+315,000→ 315,000 totalExercise: $1.34Exp: 2035-02-02→ Common Stock (315,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2025, subject to the Reporting Person's continued service as of each such date.
- [F2]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2025, in each case subject to the Reporting Person's continued service as of each such date.